Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs selected from its extensive portfolio with the potential to be safe and effective for improving patient care. The company’s product pipeline includes new uses for approved drugs and new molecular entities (“NMEs”) for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. Central to the company’s successful clinical development programs are its strong relationships with clinicians, academic medical centers, regional hospitals and specialized product and service providers. A phase II clinical development program is underway in addition to sponsored basic, translational and clinical research projects aimed at specific disease mechanisms. The company has built a robust portfolio of issued patents and pending patent applications on its products.

Tokyo Tanabe Co. Ltd., a subsidiary of Cegedim SA, is a Japanese company located in Tokyo. The firm produces and sells medicines.

Multimed SRL is a private company headquartered in Turin, Italy. The firm distributes medical and surgical devices. It was founded in 2007 by Maurizio Cordara Antona. Elena Neri is currently the CEO of the company.

FemmePharma Holding Co., Inc. provides clinical and pharmaceutical development services. The company was founded in 2005 and is headquartered in Wayne, PA.

Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals. Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals.” In accordance with this philosophy, as we implement our business activities we strive to realize our vision, which expresses that “Mitsubishi Tanabe Pharma strive to be a global research-driven pharmaceutical company that is trusted by communities.” As a company that is trusted and highly evaluated by patients and health care professionals as well as by society and shareholders, we will implement management with a focus on transparency and fairness while always keeping in mind the starting point of our business activities: “Everything we do is for the patients.”

Nanjing Lianzhi Pharmaceutical Technology Co., Ltd., established on 2018-01-10, Business scope includes medical technology research and development,technology transfer,technical consulting;Chemical Products(Does not contain dangerous goods),Technology research and development and technology transfer of medical devices;Healthy food,cosmetic,Primary agricultural product technology research and development;laboratory apparatus,Chemical Products(Does not contain dangerous goods),daily necessities,Pre-packaged food(With refrigeration,frozen food)(A license or approval is required to operate),Healthy food(A license or approval is required to operate)promotion of;Self-operated and agent import and export business of various commodities and technologies(Except for goods and technologies that the state restricts the company's operation or prohibits import and export).property management;(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

BioZone Laboratories, Inc. develops, manufactures and markets over the counter drugs. It products include personal and beauty care, dietary and nutritional supplements, and non-prescription drug products. The firm offers skin care, liquid soaps, creams, lotions, gels, anesthetics, homeopathic, oral spray, and wound care products. BioZone Laboratories was founded by Daniel Fisher and Brain Keller in 1989 and is headquartered in Pittsburg, CA.

Jiangsu Lianhuan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and sale of chemicals and pharmaceutical products. It offers chemical synthetic drugs, antibiotics, and various preparations and auxiliary raw materials for medical use. The company was founded on February 22, 2000 and is headquartered in Yangzhou, China.

DMI BioSciences, Inc. manufactures pharmaceutical products. It develops diagnostic tests and drugs for the medical device and biopharmaceutical industry. The company was founded by David Bar-Or in 1990 and is headquartered in Greenwood Village, CO.

Weihai Civic Information Technology Co., Ltd., established on 2014-08-22, Business scope includes general items:software development;Software outsourcing service;Information Technology Consulting Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Nisshin Flour Milling, Inc. manufactures and sells wheat flour. It supplies wheat flour and premix products for manufacturing use, as well as other related products such as wheat bran, wheat germ and rye. The company was founded in 1908 and is located in Tokyo, Japan

Jiaerke Biotechnology Nantong Co., Ltd., established on 2012-03-26, Business scope includes biotechnology research and development;Production and sales of raw materials and pharmaceutical intermediates(Hazardous chemicals excluded);Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Green Valley Pharmaceutical Co., Ltd., part of Green Valley Group Co., Ltd., is a Chinese company located in Shanghai that develops and sells drugs.\nThe company says this about itself: Shanghai Green Valley Pharmaceuticals is an innovative Chinese pharmaceutical company that pioneers new treatment strategies in the area of chronic and complex diseases. The company upholds the sacred mission of \"developing medicines that fulfill the biggest unmet medical needs for human health\", explores the pathogenesis of chronic and complex diseases with a holistic view of treatment, and focuses on breakthrough innovation in research and development of carbohydrate drugs. Green Valley is committed to becoming a global leader in carbohydrate drug innovation, providing safer and more effective drugs for patients with chronic and complex diseases, and providing better choice of treatment for diseases and improving the quality of life. Green Valley Pharmaceuticals was founded in 1997 and is headquartered in Zhangjiang Science City in Shanghai, China. It is focused on advancing research programs in neuropsychiatric diseases, cancer, cardiovascular diseases, metabolic diseases and autoimmune diseases.

Zhejiang Langsha Underwear Co., Ltd., established on 2006-07-14, Business scope includes underwear,knitwear,Manufacturing and sales of knitted fabrics;yarn sales;international trade,Domestic Trade.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Meditrina Pharmaceuticals, Inc. identifies and repurposes already marketed therapies and product candidates at advanced stages of development for new indications focused on improving women’s health disorders with unmet medical needs. The Company’s initial focus is in overlooked therapeutic areas that affect millions of women each year. These areas include gynecologic and aromatase-meditated conditions such as endometriosis and uterine fibroids.